Back
Viking Therapeutics Stock Predictions
Sponsored
VKTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
VKTX
Viking Therapeutics
Last Price:
52.62
Seasonality Move:
50.47%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Viking Therapeutics Stock Forecast
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 90.2% based on the past 9 years of stock performance.
- Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Viking Therapeutics Stock Undervalued?
The current Viking Therapeutics [VKTX] share price is $52.59. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 90.2% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics overpriced?
- Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
11.55
Prediction Charts
Market Cap:
5.86B
Price in USD:
52.59
Volume:
2.57M
Beta:
1.31
Technical Analysis
SMA50:
63.78
SMA100:
60.60
SMA200:
62.22
52-Wk Change:
354.93%
Stock Predictions
-
Is Viking Therapeutics stock public?
Yes, Viking Therapeutics is a publicly traded company. -
What is the Viking Therapeutics stock quote today?
The Viking Therapeutics stock price is 52.59 USD today. -
How to buy Viking Therapeutics stock online?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 63.53 | 64.63 | 67.73 | 62.50 |
Nov-6 | 65.59 | 65.88 | 66.38 | 62.80 |
Nov-7 | 66.10 | 68.85 | 69.10 | 64.80 |
Nov-8 | 68.74 | 68.48 | 70.41 | 65.77 |
Nov-11 | 68.80 | 63.00 | 68.87 | 62.81 |
Nov-12 | 62.46 | 60.61 | 62.50 | 57.37 |
Nov-13 | 61.23 | 55.04 | 61.23 | 54.54 |
Nov-14 | 55.00 | 53.57 | 56.00 | 53.56 |
Nov-15 | 53.18 | 49.58 | 53.20 | 48.98 |
Nov-18 | 49.10 | 49.11 | 50.51 | 47.65 |
Nov-19 | 48.75 | 51.51 | 51.68 | 47.85 |
Nov-20 | 52.70 | 51.53 | 53.04 | 50.40 |
Nov-21 | 51.30 | 51.63 | 54.28 | 50.53 |
Nov-22 | 53.07 | 52.59 | 53.52 | 51.95 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.48 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.